Abstract
Systemic lupus erythematosus (SLE) can affect the menstruation, fertility, and pregnancy outcomes of the affected subjects. There is very little data on this aspect of the disease in Indian patients. Our aim was to study the menstrual, fertility, and pregnancy outcomes in these patients in comparison with patients of rheumatoid arthritis (RA) and also to study the effect of cyclophosphamide therapy on menstrual cycles in patients with SLE. Four hundred and twenty patients of SLE (210) and RA (210) were interviewed using a standard questionnaire and available medical records used. After disease-onset, the chances of adverse pregnancy outcomes were significantly more in patients with SLE compared to RA [OR = 5.17 (2.13–12.52); p ≤ 0.001]. Compared to the National average in India, the average number of living children is lesser in patients with RA (2.39 ± 1.39, p = 0.002), but more so in patients with SLE (1.44 ± 1.35, p = 0.001). A younger age at diagnosis and cyclophosphamide therapy was found to be independently associated with menstrual irregularities after disease-onset. We conclude that pregnancy outcome in patients with SLE in India is worse in comparison to patients with RA. Average family size of patients with SLE and RA is less when compared to National average in India. Patients with SLE are more prone for menstrual irregularities, especially those who receive cyclophosphamide treatment.
Similar content being viewed by others
References
Clowse ME (2007) Lupus activity in pregnancy. Rheum Dis Clin N Am 33:237–252
Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR (1995) Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 25:184–192
Carmona F, Font J, Cervera R, Munoz F, Cararach V, Balasch J (1999) Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 83:137–142
Gonzalez-Crespo MR, Gomez-Reino JJ, Merino R, Ciruelo E, Gomez-Reino FJ, Muley R et al (1995) Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 34:737–741
Huong DL, Amoura Z, Duhaut P, Sbai A, Costedoat N, Wechsler B et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29:2571–2576
Katsifis GE, Tzioufas AG (2004) Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 13:673–678
Chandran V, Aggarwal A, Misra R (2005) Active disease during pregnancy is associated with poor foetal outcome in Indian patients with systemic lupus erythematosus. Rheumatol Int 26:152–156
Aggarwal N, Sawhney H, Vasishta K, Chopra S, Bambery P (1999) Pregnancy in patients with systemic lupus erythematosus. Aust NZ J Obstet Gynaecol 39:28–30
Gupta A, Agarwal A, Handa R (2005) Pregnancy in Indian patients with systemic lupus erythematosus. Lupus 14:926–927
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1734
Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
National Fact Sheet, NFHS-3 (2005–2006) Ministry of Health and Family Welfare. http://www.nfhsindia.org (Accessed 24 November 2007)
Khamashta MA, Hughes GRV (1996) Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 8:424–429
Kaufman RL, Kitridou RC (1982) Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus. J Rheumatol 9:549–555
Nossent HC, Swaak TJ (1990) Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 17:771–776
Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ (1999) Pregnancy outcome and family size in systemic lupus erythematosus: a case–control study. Rheumatology Oxford 38:559–563
Del Junco DJ, Annegers JF, Coulam CB, Luthra HS (1989) The relationship between rheumatoid arthritis and reproductive function. Br J Rheumatol 28(Suppl):1–33 discussion 42–45
Nelson JL, Koepsell TD, Dugowson CE, Voigt LF, Daling JR, Hansen JA (1993) Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum 36:7–14
Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus:a prospective study of 103 pregnancies. Rheumatology Oxford 41:643–650
Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52:514–521
Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE (1993) Risk for sustained amenorrhea in patients with Systemic Lupus Erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, R., Deepanjali, S., Kumar, A. et al. A comparative study of pregnancy outcomes and menstrual irregularities in northern Indian patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 30, 1581–1585 (2010). https://doi.org/10.1007/s00296-009-1192-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1192-0